Phentermine–topiramate extended-release reduces progression to T2DM

被引：0
|
作者：
机构：
来源：
Nature Reviews Endocrinology | 2014年 / 10卷 / 1期
关键词：
D O I：
10.1038/nrendo.2013.217
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] Changes in Cardiovascular Risk Associated With Phentermine and Topiramate Extended-Release in Participants With Comorbidities and a Body Mass Index ≥27 kg/m2
    Davidson, Michael H.
    Tonstad, Serena
    Oparil, Suzanne
    Schwiers, Michael
    Day, Wesley W.
    Bowden, Charles H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08): : 1131 - 1138
  • [22] T2DM/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects
    Galuska, David
    Pacal, Lukas
    Chalasova, Katarina
    Divacka, Petra
    Rehorova, Jitka
    Svojanovsky, Jan
    Hubacek, Jaroslav A.
    Lanska, Vera
    Kankova, Katerina
    GENE, 2024, 927
  • [23] An Open-label Study of Phentermine and Extended-release Topiramate in the Management of Treatment-refractory Chronic Migraine with Associated Obesity
    Rothrock, J.
    Andress-Rothrock, D.
    Curreri, T.
    HEADACHE, 2014, 54 (08): : 1418 - 1419
  • [24] SECOND PROSPECTIVE, PHARMACOEPIDEMIOLOGIC DATABASE ANALYSIS OF PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE USAGE FROM A REPRESENTATIVE US SAMPLE OF OLDER PATIENTS
    Peterson, C. A.
    Steelman, X.
    Varghese, S. T.
    VALUE IN HEALTH, 2015, 18 (03) : A293 - A293
  • [25] Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
    Garvey, William Timothy
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) : 741 - 756
  • [26] Pharmacokinetic Equivalence between Immediate-Release and Extended-Release Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    ANNALS OF NEUROLOGY, 2011, 70 : S32 - S33
  • [27] Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release
    Garvey, W. Timothy
    Ryan, Donna H.
    Bohannon, Nancy J. V.
    Kushner, Robert F.
    Rueger, Miriam
    Dvorak, Roman V.
    Troupin, Barbara
    DIABETES CARE, 2014, 37 (12) : 3309 - 3316
  • [28] COST-EFFECTIVENESS ANALYSIS OF XIGDUO (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) FOR MANAGING TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS
    Bao, H.
    Liu, Q.
    Peng, X.
    Xuan, J.
    VALUE IN HEALTH, 2024, 27 (06) : S122 - S122
  • [29] USL255 extended-release topiramate for the treatment of epilepsy
    Chung, Steve
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (10) : 1127 - 1137
  • [30] Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
    Garvey, W. Timothy
    Ryan, Donna H.
    Henry, Robert
    Bohannon, Nancy J. V.
    Toplak, Hermann
    Schwiers, Michael
    Troupin, Barbara
    Day, Wesley W.
    DIABETES CARE, 2014, 37 (04) : 912 - 921
12345